Newsletter | July 24, 2024

07.24.24 -- EU And U.S. State Regulations For AI

SPONSOR

Bioprocess Online is excited to introduce Bio-Expo Live, a series of live virtual events designed to empower biopharma professionals with the chance to conveniently explore the newest equipment and offerings in Upstream Bioprocessing, Downstream Bioprocessing and Bioprocess Quality, Data, and Analytical Solutions. Registration is free, reserve your spot today!

FEATURED ARTICLE

When Consumer Protection, Unfair Trade Practices, And AI Collide

The EU, and a growing number of U.S. state governments, are extending consumer protection laws to AI technologies. Life sciences companies should monitor new policy developments and understand how and where specific uses of AI will be regulated.

SPONSOR

Explore the forefront of precision medicine at the Advancing Precision Medicine Conference and Exhibition in Philadelphia, November 1-2. Engage with cutting-edge research featuring experts who are shaping the future of healthcare. Discover new insights into personalized treatments, genomic advancements, and innovative technologies revolutionizing patient care. Expand your knowledge and network with leaders driving the field forward. View the agenda and register today!

INDUSTRY INSIGHTS

The Challenges And Opportunities Of Antibody Therapies

Antibody-based therapeutics are increasing in popularity. Analyze the hurdles of antibody development and manufacturing, and explore exciting developments.

Delivering Genetic Editing Therapies To Market

Manufacturers with proven expertise in areas like viral vector production and analytics are needed now more than ever to get breakthrough, deliverable gene editing therapies to patients.

The Write Side Of AI: Augmenting Capabilities, Not Replacing Them

AI applications in medical writing are in their infancy, and the technology suffers several shortcomings including plagiarism, copyright infringement, and misinformation dissemination.

High Throughput Screening Tools For Purification Of Bispecifics

Review the potential of high-throughput screening for identifying optimal purification strategies for various bispecific formats and facilitating the development of promising therapeutic candidates.

Automating Cell Based Assays, Reducing Variability And Time To Results

Cell-based assays present a challenge due to inherent biological variation in the starting materials. Explore the development of a cell-based potency assay implemented on an automated platform.